Cold & Cough Remedies - Norway | Statista Market Forecast

In 2024, the revenue in the Cold & Cough Remedies market market in Norway amounts to US$27.76m.
It is projected that the market will experience an annual growth rate of 2.80% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue in this market, with US$11.19bn in 2024.
Considering the total population, per person revenues of US$5.03 are generated in Norway in 2024.
The demand for natural and herbal cold & cough remedies is on the rise in Norway, as consumers prioritize holistic and sustainable healthcare solutions.

Definition:
The Cold and Cough market comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies market in Norway has been experiencing steady growth in recent years, driven by customer preferences for natural and organic products, as well as increasing awareness about the importance of maintaining a healthy immune system.

Customer preferences: In Norway, there is a growing demand for natural and organic cold and cough remedies. Consumers are becoming more conscious about the ingredients used in these products and are actively seeking out options that are free from artificial additives and chemicals. This shift in consumer preferences is driven by a desire for healthier and more sustainable options, as well as a general trend towards clean and natural living.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in Norway is the rising popularity of herbal remedies. Traditional herbal medicines, such as Echinacea and elderberry, are known for their immune-boosting properties and have gained significant traction among consumers. Additionally, there is a growing interest in natural remedies that are backed by scientific research, such as vitamin C and zinc supplements.Another trend in the market is the increasing availability of over-the-counter (OTC) cold and cough remedies. Pharmacies and convenience stores are expanding their range of OTC products, making it easier for consumers to access these remedies without a prescription. This convenience factor has contributed to the overall growth of the market.

Local special circumstances: Norway's cold and harsh climate contributes to a higher prevalence of cold and coughs among the population. The long winters and low temperatures make people more susceptible to respiratory illnesses, leading to a higher demand for cold and cough remedies. This local special circumstance creates a favorable environment for the growth of the market.

Underlying macroeconomic factors: Norway has a strong economy with high disposable income levels. This allows consumers to prioritize their health and wellness, including investing in cold and cough remedies. Additionally, the country has a well-developed healthcare system that emphasizes preventive care, which further drives the demand for these products.In conclusion, the Cold & Cough Remedies market in Norway is growing due to customer preferences for natural and organic products, the popularity of herbal remedies, the increasing availability of OTC products, the local special circumstance of a cold climate, and the underlying macroeconomic factors of a strong economy and emphasis on preventive healthcare.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.